Cargando…
HIV envelope trimer-elicited autologous neutralizing antibodies bind a region overlapping the N332 glycan supersite
To date, immunization studies of rabbits with the BG505 SOSIP.664 HIV envelope glycoprotein trimers have revealed the 241/289 glycan hole as the dominant neutralizing antibody epitope. Here, we isolated monoclonal antibodies from a rabbit that did not exhibit glycan hole–dependent autologous serum n...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7274786/ https://www.ncbi.nlm.nih.gov/pubmed/32548265 http://dx.doi.org/10.1126/sciadv.aba0512 |
_version_ | 1783542660830593024 |
---|---|
author | Nogal, Bartek McCoy, Laura E. van Gils, Marit J. Cottrell, Christopher A. Voss, James E. Andrabi, Raiees Pauthner, Matthias Liang, Chi-Hui Messmer, Terrence Nedellec, Rebecca Shin, Mia Turner, Hannah L. Ozorowski, Gabriel Sanders, Rogier W. Burton, Dennis R. Ward, Andrew B. |
author_facet | Nogal, Bartek McCoy, Laura E. van Gils, Marit J. Cottrell, Christopher A. Voss, James E. Andrabi, Raiees Pauthner, Matthias Liang, Chi-Hui Messmer, Terrence Nedellec, Rebecca Shin, Mia Turner, Hannah L. Ozorowski, Gabriel Sanders, Rogier W. Burton, Dennis R. Ward, Andrew B. |
author_sort | Nogal, Bartek |
collection | PubMed |
description | To date, immunization studies of rabbits with the BG505 SOSIP.664 HIV envelope glycoprotein trimers have revealed the 241/289 glycan hole as the dominant neutralizing antibody epitope. Here, we isolated monoclonal antibodies from a rabbit that did not exhibit glycan hole–dependent autologous serum neutralization. The antibodies did not compete with a previously isolated glycan hole–specific antibody but did compete with N332 glycan supersite broadly neutralizing antibodies. A 3.5-Å cryoEM structure of one of the antibodies in complex with the BG505 SOSIP.v5.2 trimer demonstrated that while the epitope recognized overlapped the N332 glycan supersite by contacting the GDIR motif at the base of V3, primary contacts were located in the variable V1 loop. These data suggest that strain-specific responses to V1 may interfere with broadly neutralizing responses to the N332 glycan supersite and vaccine immunogens may require engineering to minimize these off-target responses or steer them toward a more desirable pathway. |
format | Online Article Text |
id | pubmed-7274786 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | American Association for the Advancement of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-72747862020-06-15 HIV envelope trimer-elicited autologous neutralizing antibodies bind a region overlapping the N332 glycan supersite Nogal, Bartek McCoy, Laura E. van Gils, Marit J. Cottrell, Christopher A. Voss, James E. Andrabi, Raiees Pauthner, Matthias Liang, Chi-Hui Messmer, Terrence Nedellec, Rebecca Shin, Mia Turner, Hannah L. Ozorowski, Gabriel Sanders, Rogier W. Burton, Dennis R. Ward, Andrew B. Sci Adv Research Articles To date, immunization studies of rabbits with the BG505 SOSIP.664 HIV envelope glycoprotein trimers have revealed the 241/289 glycan hole as the dominant neutralizing antibody epitope. Here, we isolated monoclonal antibodies from a rabbit that did not exhibit glycan hole–dependent autologous serum neutralization. The antibodies did not compete with a previously isolated glycan hole–specific antibody but did compete with N332 glycan supersite broadly neutralizing antibodies. A 3.5-Å cryoEM structure of one of the antibodies in complex with the BG505 SOSIP.v5.2 trimer demonstrated that while the epitope recognized overlapped the N332 glycan supersite by contacting the GDIR motif at the base of V3, primary contacts were located in the variable V1 loop. These data suggest that strain-specific responses to V1 may interfere with broadly neutralizing responses to the N332 glycan supersite and vaccine immunogens may require engineering to minimize these off-target responses or steer them toward a more desirable pathway. American Association for the Advancement of Science 2020-06-05 /pmc/articles/PMC7274786/ /pubmed/32548265 http://dx.doi.org/10.1126/sciadv.aba0512 Text en Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY). http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Nogal, Bartek McCoy, Laura E. van Gils, Marit J. Cottrell, Christopher A. Voss, James E. Andrabi, Raiees Pauthner, Matthias Liang, Chi-Hui Messmer, Terrence Nedellec, Rebecca Shin, Mia Turner, Hannah L. Ozorowski, Gabriel Sanders, Rogier W. Burton, Dennis R. Ward, Andrew B. HIV envelope trimer-elicited autologous neutralizing antibodies bind a region overlapping the N332 glycan supersite |
title | HIV envelope trimer-elicited autologous neutralizing antibodies bind a region overlapping the N332 glycan supersite |
title_full | HIV envelope trimer-elicited autologous neutralizing antibodies bind a region overlapping the N332 glycan supersite |
title_fullStr | HIV envelope trimer-elicited autologous neutralizing antibodies bind a region overlapping the N332 glycan supersite |
title_full_unstemmed | HIV envelope trimer-elicited autologous neutralizing antibodies bind a region overlapping the N332 glycan supersite |
title_short | HIV envelope trimer-elicited autologous neutralizing antibodies bind a region overlapping the N332 glycan supersite |
title_sort | hiv envelope trimer-elicited autologous neutralizing antibodies bind a region overlapping the n332 glycan supersite |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7274786/ https://www.ncbi.nlm.nih.gov/pubmed/32548265 http://dx.doi.org/10.1126/sciadv.aba0512 |
work_keys_str_mv | AT nogalbartek hivenvelopetrimerelicitedautologousneutralizingantibodiesbindaregionoverlappingthen332glycansupersite AT mccoylaurae hivenvelopetrimerelicitedautologousneutralizingantibodiesbindaregionoverlappingthen332glycansupersite AT vangilsmaritj hivenvelopetrimerelicitedautologousneutralizingantibodiesbindaregionoverlappingthen332glycansupersite AT cottrellchristophera hivenvelopetrimerelicitedautologousneutralizingantibodiesbindaregionoverlappingthen332glycansupersite AT vossjamese hivenvelopetrimerelicitedautologousneutralizingantibodiesbindaregionoverlappingthen332glycansupersite AT andrabiraiees hivenvelopetrimerelicitedautologousneutralizingantibodiesbindaregionoverlappingthen332glycansupersite AT pauthnermatthias hivenvelopetrimerelicitedautologousneutralizingantibodiesbindaregionoverlappingthen332glycansupersite AT liangchihui hivenvelopetrimerelicitedautologousneutralizingantibodiesbindaregionoverlappingthen332glycansupersite AT messmerterrence hivenvelopetrimerelicitedautologousneutralizingantibodiesbindaregionoverlappingthen332glycansupersite AT nedellecrebecca hivenvelopetrimerelicitedautologousneutralizingantibodiesbindaregionoverlappingthen332glycansupersite AT shinmia hivenvelopetrimerelicitedautologousneutralizingantibodiesbindaregionoverlappingthen332glycansupersite AT turnerhannahl hivenvelopetrimerelicitedautologousneutralizingantibodiesbindaregionoverlappingthen332glycansupersite AT ozorowskigabriel hivenvelopetrimerelicitedautologousneutralizingantibodiesbindaregionoverlappingthen332glycansupersite AT sandersrogierw hivenvelopetrimerelicitedautologousneutralizingantibodiesbindaregionoverlappingthen332glycansupersite AT burtondennisr hivenvelopetrimerelicitedautologousneutralizingantibodiesbindaregionoverlappingthen332glycansupersite AT wardandrewb hivenvelopetrimerelicitedautologousneutralizingantibodiesbindaregionoverlappingthen332glycansupersite |